Monograph
Role of Biologics in Patients with Refractory Disease

Estimated Time of Completion

1 hour 15 minutes

Description

This activity was presented at the Cleveland Clinic Richard J. Fasenmyer Center of Clinical Immunology Biologic Therapies for Autoimmune and Inflammatory Disease States Summit mini symposium on Role of Biologics in Patients. The monograph will focus on refractory RA, refractory Sjogren’s disease, refractory ankylosing spondylitis, idiopathic inflammatory myopathy failing standard therapy, refractory sarcoidosis and refractory systemic vasculitits.

Objectives

At the conclusion of this activity, the participant will be able to:

1. Recognize and diagnose refractory states of autoimmunity and inflammation, including these diseases: rheumatoid arthritis, vasculitis, psoriasis, inflammatory bowel disease states.
2. Evaluate the risks and benefits of using biologic therapies as options in patients with refractory autoimmune and/or inflammatory diseases.

Target Audience

This activity will be directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinics
Cleveland, Ohio

Author / Faculty

Daniel Culver, DO; Jack Cush, MD; Jonathan Kay, MD; Carol Langford, MD, MHS; Chester Oddis, MD; E. William St. Clair, MD

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:

Daniel Culver, DO